Laman UtamaACUR • OTCMKTS
Acura Pharmaceuticals Inc
$0.00020
13 Jan, 12:18:04 PG GMT-5 · USD · OTCMKTS · Penafian
SahamSekuriti tersenarai ASIbu pejabat di AS
Tutup sebelumnya
$0.00020
Julat tahun
$0.00020 - $0.75
Permodalan pasaran
13.27K USD
Bilangan Purata
3.67K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)2021Perubahan T/T
Hasil
1.56J-56.22%
Perbelanjaan pengendalian
1.25J-33.32%
Pendapatan bersih
-879.00K27.24%
Margin untung bersih
-56.24-66.19%
Pendapatan bagi setiap syer
——
EBITDA
-1.14J-3,360.00%
Kadar cukai berkesan
——
Jumlah aset
Jumlah liabiliti
(USD)2021Perubahan T/T
Pelaburan tunai dan jangka pendek
65.00K-84.26%
Jumlah aset
860.00K-50.46%
Jumlah liabiliti
682.00K-91.06%
Jumlah ekuiti
178.00K—
Syer tertunggak
66.00J—
Harga kepada buku
∞—
Pulangan pada aset
-58.46%—
Pulangan pada modal
-200.73%—
Perubahan bersih dalam tunai
(USD)2021Perubahan T/T
Pendapatan bersih
-879.00K27.24%
Tunai daripada operasi
-742.00K-3.20%
Tunai daripada pelaburan
——
Tunai daripada pembiayaan
394.00K45.93%
Perubahan bersih dalam tunai
-348.00K22.49%
Aliran tunai bebas
-1.10J-238.17%
Perihal
Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR". Wikipedia
Diasaskan
1935
Pekerja
9
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama